
Chugai Pharmaceutical Co Ltd
CHGCY · OTC · Pharmaceuticals, Biotech · Founded 1925
Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo.
Current Price
$21.52
Market Cap
$71.4B
Return Since Last Split
-18%
Last Split
Jul 6, 2020
Total Splits
1
Cumulative Multiple
12×
What If You Bought CHGCY Earlier?
Investment
Purchase Date (Before Split)
Worth Today
$25,824
1,200 shares · 12×
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jul 6, 2020 | $26.71 | 12-for-1 | 12× | 12× |
Chugai Pharmaceutical Co Ltd Market Cap Timeline
Validated annual market-cap history is available from 2003. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.
Frequently Asked Questions
Chugai Pharmaceutical Co Ltd's latest record in the split calendar is a 12-for-1 forward split effective 2020-07-06.